These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 16190794

  • 1. Serum zinc correlates with parent- and teacher- rated inattention in children with attention-deficit/hyperactivity disorder.
    Arnold LE, Bozzolo H, Hollway J, Cook A, DiSilvestro RA, Bozzolo DR, Crowl L, Ramadan Y, Williams C.
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):628-36. PubMed ID: 16190794
    [Abstract] [Full Text] [Related]

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 3. Changed Plasma Levels of Zinc and Copper to Zinc Ratio and Their Possible Associations with Parent- and Teacher-Rated Symptoms in Children with Attention-Deficit Hyperactivity Disorder.
    Viktorinova A, Ursinyova M, Trebaticka J, Uhnakova I, Durackova Z, Masanova V.
    Biol Trace Elem Res; 2016 Jan; 169(1):1-7. PubMed ID: 26063047
    [Abstract] [Full Text] [Related]

  • 4. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM, Earls MF.
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [Abstract] [Full Text] [Related]

  • 5. Can parent reports serve as a proxy for teacher ratings in medication management of attention-deficit hyperactivity disorder?
    Lavigne JV, Dulcan MK, LeBailly SA, Binns HJ.
    J Dev Behav Pediatr; 2012 May; 33(4):336-42. PubMed ID: 22371012
    [Abstract] [Full Text] [Related]

  • 6. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M, Yildirim F, Kandil S, Bekaroğlu M, Yildirmiş S, Değer O, Ulgen M, Yildiran A, Aksu H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [Abstract] [Full Text] [Related]

  • 7. Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder.
    Oner O, Oner P, Bozkurt OH, Odabas E, Keser N, Karadag H, Kizilgün M.
    Child Psychiatry Hum Dev; 2010 Aug; 41(4):441-7. PubMed ID: 20238159
    [Abstract] [Full Text] [Related]

  • 8. Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data.
    DuPaul GJ, Reid R, Anastopoulos AD, Lambert MC, Watkins MW, Power TJ.
    Psychol Assess; 2016 Feb; 28(2):214-25. PubMed ID: 26011476
    [Abstract] [Full Text] [Related]

  • 9. Executive function impairments in children with attention-deficit hyperactivity disorder: do they differ between school and home environments?
    Mares D, McLuckie A, Schwartz M, Saini M.
    Can J Psychiatry; 2007 Aug; 52(8):527-34. PubMed ID: 17955916
    [Abstract] [Full Text] [Related]

  • 10. Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Hardy KK, Kollins SH, Murray DW, Riddle MA, Greenhill L, Cunningham C, Abikoff HB, McCracken JT, Vitiello B, Davies M, McGough JJ, Posner K, Skrobala AM, Swanson JM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ.
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):621-34. PubMed ID: 17979582
    [Abstract] [Full Text] [Related]

  • 11. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ, Chen CK, Huang YS.
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [Abstract] [Full Text] [Related]

  • 12. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders.
    Pearson DA, Aman MG, Arnold LE, Lane DM, Loveland KA, Santos CW, Casat CD, Mansour R, Jerger SW, Ezzell S, Factor P, Vanwoerden S, Ye E, Narain P, Cleveland LA.
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):284-91. PubMed ID: 22849541
    [Abstract] [Full Text] [Related]

  • 13. Reliable ratings or reading tea leaves: can parent, teacher, and clinician behavioral ratings of preschoolers predict ADHD at age six?
    O'Neill S, Schneiderman RL, Rajendran K, Marks DJ, Halperin JM.
    J Abnorm Child Psychol; 2014 May; 42(4):623-34. PubMed ID: 24085388
    [Abstract] [Full Text] [Related]

  • 14. Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
    Murray DW, Kollins SH, Hardy KK, Abikoff HB, Swanson JM, Cunningham C, Vitiello B, Riddle MA, Davies M, Greenhill LL, McCracken JT, McGough JJ, Posner K, Skrobala AM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ.
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):605-20. PubMed ID: 17979581
    [Abstract] [Full Text] [Related]

  • 15. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.
    Bralten J, Franke B, Waldman I, Rommelse N, Hartman C, Asherson P, Banaschewski T, Ebstein RP, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Oosterlaan J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Buitelaar JK, Arias-Vásquez A.
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1204-1212.e1. PubMed ID: 24157394
    [Abstract] [Full Text] [Related]

  • 16. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.
    Biederman J, Gao H, Rogers AK, Spencer TJ.
    Biol Psychiatry; 2006 Nov 15; 60(10):1106-10. PubMed ID: 16806096
    [Abstract] [Full Text] [Related]

  • 17. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    Wang LJ, Chen CK, Huang YS.
    J Child Adolesc Psychopharmacol; 2015 Aug 15; 25(6):501-8. PubMed ID: 26262904
    [Abstract] [Full Text] [Related]

  • 18. Parent and teacher ratings of attention-deficit hyperactivity disorder symptoms: implications for case identification.
    Newcorn JH, Halperin JM, Schwartz S, Pascualvaca D, Wolf L, Schmeidler J, Sharma V.
    J Dev Behav Pediatr; 1994 Apr 15; 15(2):86-91. PubMed ID: 8034772
    [Abstract] [Full Text] [Related]

  • 19. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children.
    Tripp G, Schaughency EA, Clarke B.
    J Dev Behav Pediatr; 2006 Jun 15; 27(3):209-18. PubMed ID: 16775518
    [Abstract] [Full Text] [Related]

  • 20. Psychosocial factors associated with parent and teacher reports of aggression in children and adolescents with attention deficit hyperactivity disorder.
    Connolly A, Vance A.
    Aust N Z J Psychiatry; 2010 Jul 15; 44(7):667-75. PubMed ID: 20560854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.